Clinical Trial Update: A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This document provides a status update on a Phase 1/2 clinical trial evaluating JNJ-90014496 in participants with B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• JNJ-90014496

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, B-Cell | Phase 1, Phase 2 | Status: RECRUITING